Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia
Clinical trial NCT01649791 · TERMINATED
Trial details
- NCT number
- NCT01649791
- Sponsor
- Roswell Park Cancer Institute
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2012-05-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.